Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
about
A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma.Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.Molecular engineering of a dual emission near-infrared ratiometric fluorophore for the detection of pH at the organism level.Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.
P2860
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
@en
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
@nl
type
label
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
@en
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
@nl
prefLabel
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
@en
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
@nl
P2093
P2860
P1476
Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
@en
P2093
Arzu Babayigit
Candan Ozogul
Duygu Olmez
Guven Erbil
Nevin Uzuner
Osman Yilmaz
Ozkan Karaman
P2860
P304
P356
10.1080/01902140802271859
P577
2008-10-01T00:00:00Z